SCHEMBL4796600

SCHEMBL4796600

CCn1cnc2c(=O)[nH]c(=O)n(CC(C)C)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.47
ADORA2A P29274 5/20 0.47
PDE4B Q07343 5/20 0.47
PDE4C Q08493 5/20 0.47
PDE4D Q08499 5/20 0.47
BRD4 O60885 5/20 0.45
BRD2 P25440 2/20 0.45
BRD3 Q15059 2/20 0.45
BRDT Q58F21 2/20 0.45
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 5/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
PDE2A O00408 1/20 0.37
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE1C Q14123 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23797830 0.88 HTT (0.42) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL4623658 0.87 PDE4A (0.39) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL3110932 0.84 PDE1A (0.53) BRD4MEN1KMT2AHPGDPDE2A
SCHEMBL5647 0.84 ADORA2A (0.43) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL4623458 0.82 PDE4A (0.63) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL4626797 0.80 BRD4 (0.65) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL652922 0.78 MAPK1 (0.39) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL4621714 0.78 PDE4A (0.45) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL27501339 0.74 BRD4 (0.58) BRD4BRD2BRD3BRDTMEN1
SCHEMBL6251096 0.73 PDE4A (0.64) PDE4AADORA2APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008028250-A1 THERAPEUTIC AGENTS, TARGETS AND DIAGNOSTICS AUTOGEN RESEARCH PTY LTD (AU) 2008-03-13 WO disclosed
EP-0101681-A4 Antibody to a mediator activity composition and its use in a pharmaceutical composition. UNIV ROCKEFELLER (US) 1985-06-06 EP disclosed
EP-0101681-A1 Antibody to a mediator activity composition and its use in a pharmaceutical composition. UNIV ROCKEFELLER (US) 1984-03-07 EP disclosed
WO-1983000930-A1 LIPOPROTEIN LIPASE SUPPRESSION BY ENDOTOXIN-INDUCE MEDIATOR (SHOCK ASSAY) UNIV ROCKEFELLER (US) 1983-03-17 WO disclosed